Literature DB >> 1362919

Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells.

M Maio1, L Del Vecchio.   

Abstract

CD54/Intercellular Adhesion Molecule-1 (ICAM-1) is a cell adhesion molecule largely distributed among normal and neoplastic tissues. Through the binding to its ligand(s) CD54 plays a key role in cell to cell interactions leading to the immune response. Recently, CD54 expression has been investigated on hematopoietic cells: the antigen is predominantly expressed in the early stages of normal hematopoiesis and during the activation of blood cells. As regards to hematological malignancies, CD54 is strongly expressed on neoplastic cells from "stem cell derived" neoplasms. In AML, CD54 expression is related with other differentiation-linked molecules such as CD34 and HLA-DR and is significantly correlated with FAB morphological classification. In lymphoproliferative disorders, a high CD54 expression is associated with germinal centre lymphomas. This review summarizes our current understanding of CD54 with emphasis on recent advances and reference to unresolved issues such as its prognostic role in the clinical outcome of oncohematological diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362919     DOI: 10.3109/10428199209049814

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Differential expression of cell adhesion molecules in the functional compartments of lymph nodes and tonsils.

Authors:  R P Leite; M Carmo-Fonseca; J Cabeçadas; A Parreira; L Parreira
Journal:  Clin Mol Pathol       Date:  1995-04

2.  Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.

Authors:  Daniel W Sherbenou; Yang Su; Christopher R Behrens; Blake T Aftab; Olivia Perez de Acha; Megan Murnane; Shelby C Bearrows; Byron C Hann; Jeffery L Wolf; Thomas G Martin; Bin Liu
Journal:  Clin Cancer Res       Date:  2020-09-11       Impact factor: 12.531

Review 3.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

Review 4.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

5.  Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells.

Authors:  E Fonsatti; M Altomonte; S Coral; I Cattarossi; M R Nicotra; A Gasparollo; P G Natali; M Maio
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance.

Authors:  Yizhen Liu; Juan J Gu; Ling Yang; Ping-Chiao Tsai; Ye Guo; Kai Xue; Zuguang Xia; Xiaojian Liu; Fangfang Lv; Junning Cao; Xiaonan Hong; Cory Mavis; Francisco J Hernandez-Ilizaliturri; Qunling Zhang
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

7.  Fluorescence-guided fiber-optic micronavigation using microscopic identification of vascular boundary of liver segment and tumors.

Authors:  Qingliang Wang; Baifeng Qian; Michael Schäfer; Wolfgang Groß; Arianeb Mehrabi; Eduard Ryschich
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.